Merck

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$71.26-$125.14
Market Cap
$306.1B
Shares Short
28M

Financials

See more
Revenue (12 Mos)
$65B
Revenue Growth (YoY)
5%
Gross Profit (12 Mos)
$50.1B
Diluted EPS
$7.28

News

See more

Yahoo Finance • 2 hours ago

Notable healthcare headlines for the week: Viatris, Novo Nordisk, and Gilead Sciences in focus

Yahoo Finance • 6 hours ago

Pfizer Inc. (PFE) and Astellas Pharma Announce Positive Results From the Phase 3 EV-304 Clinical Trial for PADCEVTM

Yahoo Finance • yesterday

KEYTRUDA® (pembrolizumab) Plus WELIREG® (belzutifan) Given as Adjuvant Therapy Reduced the Risk of Disease Recurrence or Death by 28% Compared to KEYTRUDA Monotherapy in Certain Patients With Earlier-Stage Renal Cell Carcinoma (RCC)

Yahoo Finance • yesterday

WELIREG® (belzutifan) Plus LENVIMA® (lenvatinib) Reduced the Risk of Disease Progression or Death by 30% Compared to Cabozantinib in Certain Previously Treated Patients With Advanced Renal Cell Carcinoma (RCC)

About

CEO
Mr. Robert M. Davis J.D.
CFO
Ms. Caroline A. Litchfield
Address
126 East Lincoln Avenue, Rahway, NJ, United States, 07065
Sector
Healthcare
Industry
Drug Manufacturers - General
Full-Time Employees
73,000